• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氯喹口服给药于临床正常猫的药代动力学特征:猫传染性腹膜炎(FIP)潜在治疗方法的初步体内研究

Pharmacokinetic Profile of Oral Administration of Mefloquine to Clinically Normal Cats: A Preliminary In-Vivo Study of a Potential Treatment for Feline Infectious Peritonitis (FIP).

作者信息

Yu Jane, Kimble Benjamin, Norris Jacqueline M, Govendir Merran

机构信息

Sydney School of Veterinary Science, Faculty of Science, The University of Sydney, Sydney, NSW 2006, Australia.

出版信息

Animals (Basel). 2020 Jun 8;10(6):1000. doi: 10.3390/ani10061000.

DOI:10.3390/ani10061000
PMID:32521771
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7341284/
Abstract

The pharmacokinetic profile of mefloquine was investigated as a preliminary study towards a potential treatment for feline coronavirus infections (such as feline infectious peritonitis) or feline calicivirus infections. Mefloquine was administered at 62.5 mg orally to seven clinically healthy cats twice weekly for four doses and mefloquine plasma concentrations over 336 h were measured using high pressure liquid chromatography (HPLC). The peak plasma concentration (Cmax) after a single oral dose of mefloquine was 2.71 ug/mL and time to reach Cmax (Tmax) was 15 h. The elimination half-life was 224 h. The plasma concentration reached a higher level at 4.06 ug/mL when mefloquine was administered with food. Adverse effects of dosing included vomiting following administration without food in some cats. Mild increases in serum symmetric dimethylarginine (SDMA), but not creatinine, concentrations were observed. Mefloquine may provide a safe effective treatment for feline coronavirus and feline calicivirus infections in cats.

摘要

作为对猫冠状病毒感染(如猫传染性腹膜炎)或猫杯状病毒感染潜在治疗方法的初步研究,对甲氟喹的药代动力学特征进行了调查。对7只临床健康的猫每周口服两次62.5毫克甲氟喹,共给药4次,采用高压液相色谱法(HPLC)测定336小时内的甲氟喹血浆浓度。单次口服甲氟喹后的血浆峰浓度(Cmax)为2.71微克/毫升,达到Cmax的时间(Tmax)为15小时。消除半衰期为224小时。与食物一起服用甲氟喹时,血浆浓度达到较高水平,为4.06微克/毫升。给药的不良反应包括一些猫在未进食时给药后出现呕吐。观察到血清对称二甲基精氨酸(SDMA)浓度轻度升高,但肌酐浓度未升高。甲氟喹可能为猫的猫冠状病毒和猫杯状病毒感染提供一种安全有效的治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f2f/7341284/6414aa0f2513/animals-10-01000-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f2f/7341284/4941f0cf1713/animals-10-01000-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f2f/7341284/b5e986caa5b7/animals-10-01000-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f2f/7341284/6414aa0f2513/animals-10-01000-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f2f/7341284/4941f0cf1713/animals-10-01000-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f2f/7341284/b5e986caa5b7/animals-10-01000-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f2f/7341284/6414aa0f2513/animals-10-01000-g003.jpg

相似文献

1
Pharmacokinetic Profile of Oral Administration of Mefloquine to Clinically Normal Cats: A Preliminary In-Vivo Study of a Potential Treatment for Feline Infectious Peritonitis (FIP).氯喹口服给药于临床正常猫的药代动力学特征:猫传染性腹膜炎(FIP)潜在治疗方法的初步体内研究
Animals (Basel). 2020 Jun 8;10(6):1000. doi: 10.3390/ani10061000.
2
Assay validation and determination of in vitro binding of mefloquine to plasma proteins from clinically normal and FIP-affected cats.测定和确定体外盐酸甲氟喹与临床正常和猫传染性腹膜炎(FIP)患猫血浆蛋白的结合情况。
PLoS One. 2020 Aug 5;15(8):e0236754. doi: 10.1371/journal.pone.0236754. eCollection 2020.
3
In vitro hepatic metabolism of mefloquine using microsomes from cats, dogs and the common brush-tailed possum (Trichosurus vulpecula).应用猫、犬和普通帚尾袋貂(Trichosurus vulpecula)微粒体进行甲氟喹的体外肝脏代谢研究。
PLoS One. 2020 Apr 14;15(4):e0230975. doi: 10.1371/journal.pone.0230975. eCollection 2020.
4
Establishment of a Virulent Full-Length cDNA Clone for Type I Feline Coronavirus Strain C3663.建立一株 I 型猫冠状病毒 C3663 的强毒全长 cDNA 克隆。
J Virol. 2019 Oct 15;93(21). doi: 10.1128/JVI.01208-19. Print 2019 Nov 1.
5
Identification and characterisation of small molecule inhibitors of feline coronavirus replication.猫冠状病毒复制小分子抑制剂的鉴定与表征
Vet Microbiol. 2014 Dec 5;174(3-4):438-447. doi: 10.1016/j.vetmic.2014.10.030. Epub 2014 Nov 4.
6
Pathogenesis of oral type I feline infectious peritonitis virus (FIPV) infection: Antibody-dependent enhancement infection of cats with type I FIPV via the oral route.口腔型猫传染性腹膜炎病毒(FIPV)感染的发病机制:I型FIPV通过口腔途径对猫进行抗体依赖性增强感染。
J Vet Med Sci. 2019 Jun 21;81(6):911-915. doi: 10.1292/jvms.18-0702. Epub 2019 Apr 23.
7
Risk factors for feline infectious peritonitis among cats in multiple-cat environments with endemic feline enteric coronavirus.在猫肠道冠状病毒流行的多猫环境中,猫传染性腹膜炎在猫群中的危险因素。
J Am Vet Med Assoc. 1997 May 1;210(9):1313-8.
8
Circulation and genetic diversity of Feline coronavirus type I and II from clinically healthy and FIP-suspected cats in China.中国临床健康猫和疑似 FIP 猫中 I 型和 II 型猫冠状病毒的循环和遗传多样性。
Transbound Emerg Dis. 2019 Mar;66(2):763-775. doi: 10.1111/tbed.13081. Epub 2018 Dec 5.
9
Changes in some acute phase protein and immunoglobulin concentrations in cats affected by feline infectious peritonitis or exposed to feline coronavirus infection.感染猫传染性腹膜炎或暴露于猫冠状病毒感染的猫体内某些急性期蛋白和免疫球蛋白浓度的变化。
Vet J. 2004 Jan;167(1):38-44. doi: 10.1016/s1090-0233(03)00055-8.
10
Reverse Genetics for Type I Feline Coronavirus Field Isolate To Study the Molecular Pathogenesis of Feline Infectious Peritonitis.用于研究猫传染性腹膜炎的分子发病机制的 I 型猫冠状病毒田间分离株的反向遗传学。
mBio. 2018 Jul 31;9(4):e01422-18. doi: 10.1128/mBio.01422-18.

引用本文的文献

1
Feline Infectious Peritonitis: European Advisory Board on Cat Diseases Guidelines.猫传染性腹膜炎:欧洲猫病咨询委员会指南。
Viruses. 2023 Aug 31;15(9):1847. doi: 10.3390/v15091847.
2
Rottlerin-Liposome Inhibits the Endocytosis of Feline Coronavirus Infection.罗勒酮脂质体抑制猫冠状病毒感染的内吞作用。
Vet Sci. 2023 May 30;10(6):380. doi: 10.3390/vetsci10060380.
3
Feline Coronavirus Antivirals: A Review.猫冠状病毒抗病毒药物:综述

本文引用的文献

1
Antiviral Effects of Hydroxychloroquine and Type I Interferon on In Vitro Fatal Feline Coronavirus Infection.羟氯喹和 I 型干扰素对体外致死性猫冠状病毒感染的抗病毒作用。
Viruses. 2020 May 24;12(5):576. doi: 10.3390/v12050576.
2
Coronavirus Pandemic-Therapy and Vaccines.冠状病毒大流行——治疗方法与疫苗
Biomedicines. 2020 May 3;8(5):109. doi: 10.3390/biomedicines8050109.
3
In vitro hepatic metabolism of mefloquine using microsomes from cats, dogs and the common brush-tailed possum (Trichosurus vulpecula).应用猫、犬和普通帚尾袋貂(Trichosurus vulpecula)微粒体进行甲氟喹的体外肝脏代谢研究。
Pathogens. 2021 Sep 7;10(9):1150. doi: 10.3390/pathogens10091150.
4
Current status on treatment options for feline infectious peritonitis and SARS-CoV-2 positive cats.猫传染性腹膜炎和 SARS-CoV-2 阳性猫的治疗选择现状。
Vet Q. 2020 Dec;40(1):322-330. doi: 10.1080/01652176.2020.1845917.
PLoS One. 2020 Apr 14;15(4):e0230975. doi: 10.1371/journal.pone.0230975. eCollection 2020.
4
Repurposing of clinically approved drugs for treatment of coronavirus disease 2019 in a 2019-novel coronavirus-related coronavirus model.将临床批准的药物重新用于治疗 2019 年新型冠状病毒相关冠状病毒模型中的 2019 年冠状病毒病。
Chin Med J (Engl). 2020 May 5;133(9):1051-1056. doi: 10.1097/CM9.0000000000000797.
5
Diagnosis of Feline Infectious Peritonitis: A Review of the Current Literature.猫传染性腹膜炎的诊断:文献综述。
Viruses. 2019 Nov 15;11(11):1068. doi: 10.3390/v11111068.
6
Successful treatment of non-HIV progressive multifocal leukoencephalopathy: case report and literature review.成功治疗非 HIV 进行性多灶性白质脑病:病例报告及文献复习。
J Neurol. 2020 Mar;267(3):731-738. doi: 10.1007/s00415-019-09629-x. Epub 2019 Nov 14.
7
Efficacy and safety of the nucleoside analog GS-441524 for treatment of cats with naturally occurring feline infectious peritonitis.核苷类似物GS-441524治疗自然感染猫传染性腹膜炎猫的疗效和安全性。
J Feline Med Surg. 2019 Apr;21(4):271-281. doi: 10.1177/1098612X19825701. Epub 2019 Feb 13.
8
The nucleoside analog GS-441524 strongly inhibits feline infectious peritonitis (FIP) virus in tissue culture and experimental cat infection studies.核苷类似物 GS-441524 能在组织培养和实验猫感染研究中强烈抑制猫传染性腹膜炎(FIP)病毒。
Vet Microbiol. 2018 Jun;219:226-233. doi: 10.1016/j.vetmic.2018.04.026. Epub 2018 Apr 22.
9
Efficacy of a 3C-like protease inhibitor in treating various forms of acquired feline infectious peritonitis.一种类3C蛋白酶抑制剂治疗各种形式猫传染性腹膜炎的疗效
J Feline Med Surg. 2018 Apr;20(4):378-392. doi: 10.1177/1098612X17729626. Epub 2017 Sep 13.
10
Progressive multifocal leukoencephalopathy in a 44-year old male with idiopathic CD4+ T-lymphocytopenia treated with mirtazapine and mefloquine.一名44岁患有特发性CD4+ T淋巴细胞减少症的男性,在接受米氮平和甲氟喹治疗后发生进行性多灶性白质脑病。
Neurol India. 2017 Sep-Oct;65(5):1061-1064. doi: 10.4103/neuroindia.NI_535_16.